is an innovative high-tech enterprise focusing on the R&D, production and application of new cyclodextrin materials. Founded in 2010,covers area 30000m² , construction area 10000m², GMP workshop 2000m²,R&D, testing and laboratories 2000m², fixed assets 150 million yuan, testing instruments value more than 20 million yuan. We have advance R&D, quality inspection center and professional research team, maintains long-term cooperative relationship with Nankai University and Shandong University, and have many R&D platforms.
Currently, about 5% of the world's population is affected by diabetes. The main drug for diabetes is insulin, the active form is insulin monomer, which is an unstable molecule, because long-term storage, or high temperature, will adapt monomer insulin to alternative folds, rich in β-sheets, and has
According to recent market research, the vaccine market is expected to grow at a rate of 14.7% over the forecast period 2020-2026 owing to the spread of COVID-19 over the past two years. The main challenges in the vaccine development process include antigenic transfer (antigen transfer of organisms
Actarit (Acta) is acetaminophenacetic acid, which is an anti-rheumatic drug developed by Mitsubishi Chemical Industry Corporation of Japan. It has inhibitory effect on delayed allergic reaction and can be improved by reducing serum nitric oxide concentration. The early symptoms of rheumatoid arthrit
Ellagic acid is a dimerized derivative of gallic acid, a natural polyphenolic compound, widely found in pomegranate, raspberry, strawberry, blackberry, walnut, wolfberry and other soft fruit and nut plants. In addition, ellagic acid can also prevent and treat positive diseases such as inflammation,